INCY
Incyte Corporation
124.70$
-0.5%
vs. previous close
Closing price · As of: Sep 21, 2026
Ownership
Ownership Structure
Who owns Incyte Corporation (INCY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 84.2% of the shares are freely tradable; institutional investors hold 106.6%.
Institutional ownership
?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
106.6%
Insiders
?Share of the stock held by the executives, founders and major shareholders of the company itself.
1.9%
Float
?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
84.2%
Short % of float
?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
7.9%
Shares Outstanding
?Total number of shares issued. Price times share count gives market cap.
203Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Baker Bros Advisors LP | 15.17 | 30,744,412 | +0.0 | 03/31/2026 |
| BlackRock Inc | 9.36 | 18,978,198 | +3.5 | 03/31/2026 |
| Dodge & Cox | 5.90 | 11,957,326 | -2.4 | 06/30/2026 |
| Vanguard Capital Management, LLC | 5.39 | 10,930,066 | +0.0 | 03/31/2026 |
| State Street Corp | 4.76 | 9,641,384 | -0.2 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.83 | 7,759,183 | +0.0 | 03/31/2026 |
| AQR Capital Management LLC | 2.87 | 5,807,930 | -13.6 | 03/31/2026 |
| Geode Capital Management, LLC | 2.32 | 4,703,184 | -5.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Dodge & Cox Stock I | 3.92 | 7,953,128 | -4.0 | 06/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.67 | 5,407,523 | +0.3 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Cagnoni Pablo J | President, Global Head of R&D | 183,200 | 22,845,040 $ | Sep 15, 2026 | direct |
| Meury William | Chief Executive Officer | 183,129 | 22,836,186 $ | Jul 16, 2026 | direct |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | 71,797 | 8,953,086 $ | Jul 16, 2026 | direct |
| Mayes Patrick A | EVP & Chief Scientific Officer | 61,441 | 7,661,693 $ | Aug 5, 2026 | direct |
| Stein Steven H | CMO & Head of Late-Stage Dev. | 30,916 | 3,855,225 $ | Jul 16, 2026 | direct |
| Tray Thomas | Principal Accounting Officer | 21,699 | 2,705,865 $ | Jul 16, 2026 | direct |
| Hoffman Richard A. | EVP & General Counsel | 16,861 | 2,102,567 $ | Jul 16, 2026 | direct |
| Gardner David H | EVP, Chief Strategy Officer | 16,824 | 2,097,953 $ | Jul 16, 2026 | direct |
| Basi Ramitpal K | EVP, Human Resources | 10,993 | 1,370,827 $ | Aug 25, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sell | 13,985 | 120.49 | 1,685,053 |
| Sep 15, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sell | 9,233 | 120.50 | 1,112,577 |
| Sep 15, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Other | 9,233 | 71.93 | 664,130 |
| Sep 15, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Other | 6,477 | 64.25 | 416,147 |
| Sep 15, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Other | 4,551 | 61.18 | 278,430 |
| Sep 15, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Other | 2,957 | 61.76 | 182,624 |
| Aug 25, 2026 | Basi Ramitpal K | EVP, Human Resources | Other | 504 | 129.72 | 65,379 |
| Aug 19, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sell | 10,801 | 125.56 | 1,356,174 |
| Aug 12, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sell | 10,803 | 120.04 | 1,296,792 |
| Aug 5, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2,207 | 123.99 | 273,646 |
| Aug 5, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 2,207 | 106.47 | 234,979 |
| Aug 5, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sell | 10,640 | 122.69 | 1,305,422 |
| Aug 3, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 6,055 | 120.43 | 729,204 |
| Aug 3, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 6,055 | 105.43 | 638,379 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2,293 | 119.41 | 273,807 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 326 | 121.69 | 39,671 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 85 | 122.19 | 10,386 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 1,642 | 119.38 | 196,022 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 1,643 | 119.51 | 196,355 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2,864 | 119.40 | 341,962 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 4,695 | 119.39 | 560,536 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 6,171 | 119.43 | 737,003 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2,187 | 119.47 | 261,281 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 5,332 | 119.42 | 636,747 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 14,661 | 119.46 | 1,751,403 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 326 | 105.43 | 34,370 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 85 | 106.47 | 9,050 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 2,293 | 90.56 | 207,654 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 1,642 | 85.01 | 139,586 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 3,023 | 83.20 | 251,514 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 1,643 | 80.50 | 132,262 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 2,864 | 77.67 | 222,447 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 2,623 | 83.58 | 219,230 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 9,459 | 72.27 | 683,602 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 2,072 | 71.93 | 149,039 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 3,148 | 68.62 | 216,016 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 2,709 | 61.76 | 167,308 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 2,284 | 64.25 | 146,747 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 2,918 | 61.18 | 178,523 |
| Jul 31, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sell | 15,888 | 119.70 | 1,901,794 |
| Jul 16, 2026 | Hoffman Richard A. | EVP & General Counsel | Other | 7,395 | 0.00 | – |
| Jul 16, 2026 | Gardner David H | EVP, Chief Strategy Officer | Other | 7,395 | 0.00 | – |
| Jul 16, 2026 | Basi Ramitpal K | EVP, Human Resources | Other | 4,991 | 0.00 | – |
| Jul 16, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Other | 5,916 | 0.00 | – |
| Jul 16, 2026 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Other | 7,857 | 0.00 | – |
| Jul 16, 2026 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Sell | 1,093 | 115.01 | 125,706 |
| Jul 16, 2026 | Tray Thomas | Principal Accounting Officer | Other | 2,834 | 0.00 | – |
| Jul 16, 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | Other | 9,798 | 0.00 | – |
| Jul 16, 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | Sell | 1,877 | 114.73 | 215,348 |
| Jul 16, 2026 | Meury William | Chief Executive Officer | Other | 26,807 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.